Digital Breast Tomosynthesis - Global Strategic Business Report

The global market for Digital Breast Tomosynthesis was estimated at US$3.5 Billion in 2023, and is projected to reach US$7.6 Billion by 2030, growing at a CAGR of 11.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the digital breast tomosynthesis market is driven by several factors. The rising prevalence of breast cancer globally has heightened the demand for more accurate and reliable screening methods, positioning DBT as a preferred choice. Technological innovations, such as AI integration and improved image processing, have expanded the capabilities of DBT systems, making them more effective and user-friendly. Increasing awareness among women about the importance of regular breast cancer screening and the advantages of DBT over traditional methods is also driving market adoption. Moreover, supportive government policies and reimbursement frameworks in many regions are facilitating access to DBT, encouraging healthcare facilities to invest in this advanced technology. Additionally, the growing focus on personalized medicine and patient-centric care is pushing for the adoption of DBT, which offers more detailed and individualized diagnostic information. Collectively, these factors are fueling the rapid expansion and development of the digital breast tomosynthesis market.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the 2D / 3D Combination Mammography Systems segment, which is expected to reach US$1.7 Billion by 2030 with a CAGR of a 13.6%. The Standalone 3D Mammography Systems segment is also set to grow at 11.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $948.5 Million in 2023, and China, forecasted to grow at an impressive 16.1% CAGR to reach $1.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Digital Breast Tomosynthesis Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Digital Breast Tomosynthesis Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Digital Breast Tomosynthesis Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Allengers Medical Systems Ltd., Canon Medical Systems Corporation, FUJIFILM Healthcare Americas Corporation, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 86 Featured):

• Allengers Medical Systems Ltd.
• Canon Medical Systems Corporation
• FUJIFILM Healthcare Americas Corporation
• GE HealthCare PLC
• Hologic, Inc.
• I.M.S. (Internazionale Medico Scientifica) Srl
• LBN Medical
• Metaltronica SpA
• Planmed Oy
• Shanghai United Imaging Healthcare Co., LTD
• Siemens Healthcare GmbH
• Trivitron Healthcare;